Mirati Therapeutics Note From BMO, Upside Scenario Up To $200/Share: A Takeout Is Likely To Reflect Full Valuation
BMO Upside Scenario Up To $200/sh: A Takeout Is Likely To Reflect Full Valuation For Usage In The 1L NSCLC Setting. As We Previewed Earlier This Month, We Expect The Updated Data Presented At ESMO